As of 2025-11-18, the Relative Valuation of Surface Oncology Inc (SURF) is (30.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.07 USD, the upside of Surface Oncology Inc based on Relative Valuation is -2992.5%.
The range of the Relative Valuation is (32.30) - (27.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 18.1x | 16.3x |
| Forward P/E multiples | 21.2x - 29.6x | 24.4x |
| Fair Price | (32.30) - (27.59) | (30.95) |
| Upside | -3119.0% - -2678.3% | -2992.5% |
| Date | P/E |